There is resistance overhead for the stock of the health plan operator after a spurt upward, so wait to buy it on a breakout over a key price.
Traders could go long ISRG at current levels.
All eyes will be on JNJ as it releases its numbers Tuesday.
Stand aside and let things "shake out".
SWAV has more to go on the upside.
Let's check out the charts of this maker of a skin rejuvenation device.
The hearing aid company's shares fell on word that it is the subject of federal investigation, but just because the stock is cheap doesn't make it a bargain.
ProQR Therapeutics, Oscar Health and Hims & Hers Health appear to have promising futures.
The charts and indicators tell us the correction is over.
Let's check the charts and indicators.